Loading ...

Access to quality vaccines, medicines, and health technologies in Rwanda

KWIGIRA
Rwanda

Project summary

Strengthen entrepreneurship and to improve the business environment and attractiveness of investment in Rwanda, including pharmaceutical investments.

Code RWA21001
Start date 18 April 2022
End date 24 April 2026
Stage Execution
Donor European Union
Sector 25010 Business support services and institutions
Budget 7 042 056.00 €

General objective

The business environment and attractiveness of Rwanda for pharmaceutical investments is enhanced to ensure access to quality vaccines, medicines, and health technologies in Africa

Specific objective

A - To assist Rwanda FDA to adequately perform its mission to protect public health and to reach and maintain maturity level 3 of WHO Global Benchmarking Tool (GBT) to fully regulate pharmaceutical products including vaccines manufacturing in Rwanda.

News

No news

Related links
  • No related links
Related documents
  • No related documents
Export data